However, a wide range of malignancies other than prostate cancer have also been reported to express PSMA as part of tumor neovasculature [7–9] with 68Ga-PSMA avidity described in cases of breast cancer [10], renal cell carcinoma [11], glioblastoma multiforme [12], hepatocellular carcinoma [13], differentiated thyroid cancer [14], colorectal carcinoma [15], non-small cell lung cancer [16] and follicular lymphoma [17]. Here, FOLH1 is linked to prostate carcinoma.